Effect of Transcutaneous Electrical Nerve Stimulation Based on Wrist-ankle Acupuncture Theory on EC50 of Remifentanil Inhibiting Responses to Tracheal Intubation Under General Anesthesia
Launched by CHANGHAI HOSPITAL · Dec 23, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new approach to help manage pain and stress during a medical procedure called tracheal intubation, which is commonly done under general anesthesia. The researchers want to see if a method called Transcutaneous Electrical Nerve Stimulation based on Wrist-Ankle Acupuncture theory (TENS-WAA) can effectively reduce the amount of a pain medication, remifentanil, needed during this procedure. TENS-WAA is a non-invasive treatment that uses electrical stimulation to help relieve pain without the need for needles, making it a safer and easier option for patients.
To participate in this study, individuals need to be between 18 and 64 years old, have a body mass index (BMI) of 30 or less, and be in generally good health (ASA grade I-III). However, those with certain conditions, such as difficult airways, severe heart disease, or those who have had recent acupuncture, will not be eligible. Participants will be closely monitored during the trial and can expect to help researchers understand how effective this new method is in improving comfort during anesthesia. This information could be important for better pain management in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 18-64 years old;
- • ASA grade I-Ⅲ;
- • BMI≤30kg/m2.
- Exclusion Criteria:
- • Patients predicted to have difficult airways or those experiencing unsuccessful intubation processes;
- • Individuals with psychiatric disorders, cognitive impairments, or other conditions that preclude cooperation;
- • Patients who have received acupuncture treatment within the past three months or are undergoing routine acupuncture therapy;
- • Individuals with a history of severe cardiovascular disease, hyperthyroidism, or asthma;
- • Patients with contraindications to transcutaneous electrical nerve stimulation (TENS), including those with pacemakers, metallic implants, allergies to surface electrodes, skin sensory disorders, skin lesions, scars, or unhealed adhesions.
About Changhai Hospital
Changhai Hospital is a leading medical institution dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to excellence, the hospital integrates cutting-edge medical technologies and a multidisciplinary approach to patient care. Changhai Hospital actively collaborates with research organizations and healthcare professionals to conduct rigorous clinical trials aimed at developing new treatments and improving patient outcomes. By prioritizing patient safety and ethical standards, the hospital plays a pivotal role in contributing to the advancement of medical knowledge and the enhancement of therapeutic options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported